Expression of angiopoietin-1, angiopoietin-2, and tie receptors after middle cerebral artery occlusion in the rat

American Journal of Pathology

Volumn 157, Issue 5, 2000, Pages 1473-1483

  Beck, Heike ^a   Acker, Till ^a   Wiessner, Christoph ^b   Allegrini, Peter R ^b   Plate, Karl H ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; ANGIOPOIETIN RECEPTOR TIE 2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; ENDOTHELIUM CELL; GLIA CELL; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RNA ANALYSIS;

EID: 0033678506     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64786-4     Document Type: Article

References (45)

1. Role of angiogenesis in patients with cerebral ischemic stroke
2. PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: Relation to outcome
3. Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct
4. Hypoxia-induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia
5. Mechanisms of angiogenesis
6. Mechanisms of angiogenesis in the brain
7. Expression of vascular endothelial growth factor during embryonic angiogenesis and endothelial cell differentiation
8. Coordinate expression of vascular endothelial growth factor receptor-1 (fit-1) and its ligand suggests a paracrine regulation of routine vascular development
9. High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis
10. Vascular endothelial growth factor expression in transient focal cerebral ischemia in the rat
11. VEGF and flt. Expression time kinetics in rat brain infarct
12. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) following permanent and transient occlusion of the middle cerebral artery in the rat
13. Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats
14. The angiopoietins: Yin and Yang in angiogenesis
15. Assignment of ANGPT4, ANGPT1, and ANGPT2 encoding angiopoietins 4, 1 and 2 to human chromosome bands 20p13, 8q22.3->q23 and 8p23.1, respectively, by in situ hybridization and radiation hybrid mapping
16. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis
17. Angiopoietin-3, a novel member of the angiopoietin family
18. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
19. Angiopoietins 3 and 4: Diverging gene counterparts in mice and humans
20. Tie2 receptor expression and phosphorylation in cultured cells and mouse tissues
21. Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation
22. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues
23. The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells
24. Dominant-negative and targeted null mutations in the endothelial receptor tyrosine kinase, tek, reveal a critical role in vasculogenesis of the embryo
25. Signaling vascular morphogenesis and maintenance
26. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis
27. New model of tumor angiogenesis: Dynamic balance between vessel regression and growth mediated by angiopoietins and VEGF
28. Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF
29. Focal cerebral ischaemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion
30. Characterization of the cerebroprotective efficacy of the competitive NMDA receptor antagonist CGP40116 in a rat model of focal cerebral ischemia: An in vivo magnetic resonance imaging study
31. Application of magnetic resonance imaging to the measurement of neurodegeneration in rat brain: MRI data correlate strongly with histology and enzymatic analysis
32. Spin diffusion measurements: Spin echoes in the presence of a time-dependent field gradient
33. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis
34. Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis
35. Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization
36. Is angiopoietin-2 necessary for the initiation of tumor angiogenesis?
37. Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia
38. Regulation of angiopoietin-2 mRNA levels in bovine microvascular endothelial cells by cytokines and hypoxia
39. Hypoxia and vascular endothelial growth factor selectively up-regulate angiopoietin-2 in bovine microvascular endothelial cells
40. Hypoxia and related conditions
41. Correlation between rCBF and histological changes following temporary middle cerebral artery occlusion
42. Endothelial Tie2/Tek ligands angiopoietin-1 (ANGPT1) and angiopoietin-2 (ANGPT2): Regional localization of the human genes to 8q22.3-q23 and 8p23
43. The mouse tie receptor tyrosine kinase gene: Expression during embryonic angiogenesis
44. The endothelial receptor tyrosine kinase tie-1 is upregulated by hypoxia and vascular endothelial growth factor
45. Induction of angiopoietin and Tie receptor mRNA expression after cerebral ischemia-reperfusion